This Wealth Manager Just Dumped Its Entire $3.5 Million Stake in the iShares Biotech ETF

This Wealth Manager Just Dumped Its Entire $3.5 Million Stake in the iShares Biotech ETF

Key PointsSold 24,270 shares of IBB; estimated trade value of $3.50 million based on quarterly average pricing. Net position value decreased by $3.50 million. Represents a 3.27% shift in 13F reportable assets under management. Rye Brook Capital now holds zero shares, with no remaining value in IBB. Sale comes amid fund downsizing; the position was 1.8% of the fund's AUM in the previous quarter. These 10 stocks could mint the next wave of million…